These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27354327)

  • 1. M1761K mutation in the von Willebrand factor A3 domain associated with impaired collagen binding and without platelet dysfunction.
    Ong DM; Aumann H; Andrews RK; Gardiner EE; Rodgers SE; Davis AK
    Haemophilia; 2016 Jul; 22(4):e345-6. PubMed ID: 27354327
    [No Abstract]   [Full Text] [Related]  

  • 2. 2B or not 2B? What is the role of VWF in platelet-matrix interactions? And what is the role of the VWF:CB in VWD diagnostics? These are the questions.
    Favaloro EJ
    J Thromb Haemost; 2006 Apr; 4(4):892-4. PubMed ID: 16634760
    [No Abstract]   [Full Text] [Related]  

  • 3. von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.
    Baronciani L; Federici AB; Cozzi G; Canciani MT; Mannucci PM
    J Thromb Haemost; 2006 Sep; 4(9):2088-90. PubMed ID: 16961623
    [No Abstract]   [Full Text] [Related]  

  • 4. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.
    Favaloro EJ
    Thromb Haemost; 2008 Mar; 99(3):630-1; author reply 632-3. PubMed ID: 18327414
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect.
    Fels S; Boeckelmann D; Glonnegger H; Büchsel M; Zieger B
    Hamostaseologie; 2023 Apr; 43(2):122-125. PubMed ID: 35104900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.
    Federici AB; Canciani MT
    Haematologica; 2009 May; 94(5):610-5. PubMed ID: 19407316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD.
    Flood VH; Lederman CA; Wren JS; Christopherson PA; Friedman KD; Hoffmann RG; Montgomery RR
    J Thromb Haemost; 2010 Jun; 8(6):1431-3. PubMed ID: 20345715
    [No Abstract]   [Full Text] [Related]  

  • 9. New light on an old story: von Willebrand factor binding to collagen.
    Chen J; López JA
    J Thromb Haemost; 2006 Oct; 4(10):2148-50. PubMed ID: 16999849
    [No Abstract]   [Full Text] [Related]  

  • 10. A3 domain is essential for interaction of von Willebrand factor with collagen type III.
    Lankhof H; van Hoeij M; Schiphorst ME; Bracke M; Wu YP; Ijsseldijk MJ; Vink T; de Groot PG; Sixma JJ
    Thromb Haemost; 1996 Jun; 75(6):950-8. PubMed ID: 8822592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
    Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
    Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotype and genotype analysis of three Chinese pedigrees with von Willebrand disease].
    Qin HH; Wang XF; Ding QL; Xu GQ; Zhang LW; Dai J; Lu YL; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):99-102. PubMed ID: 21429375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation.
    Shen MC; Lin JS; Lin DS; Hsu SC; Lin B
    Thromb Res; 2003; 112(5-6):291-5. PubMed ID: 15041272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor and platelet function.
    Moroose R; Hoyer LW
    Annu Rev Med; 1986; 37():157-63. PubMed ID: 2939788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis.
    Favaloro EJ; Mohammed S; Oliver S
    Haemophilia; 2018 Jan; 24(1):20-23. PubMed ID: 29168609
    [No Abstract]   [Full Text] [Related]  

  • 19. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
    McNicol A; Eyer E; Jackson EC; Israels SJ
    Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.